By Justin Singer / Special To The Washington Post
A new study on cannabis compounds and the coronavirus got a lot of attention last week because it suggests that consuming certain cannabinoid acids may help treat or prevent covid-19. Predictably, the Internet was aflutter with the idea that the solution to the pandemic might be weed; which is very convenient if you already like weed.
“All this time we’ve been listening to the CDC, we should have been eating CBD,” Jimmy Kimmel joked on his show last Wednesday night. The study is promising and the excitement understandable, but the reality is that we won’t know whether cannabinoids are a safe and effective treatment for covid-19 until they’re tested in human trials.
This seems straightforward enough, but human trials take years in normal times for normal compounds. Meanwhile, we’re in covid times, and we’re talking about marijuana. And the Food and Drug Administration has made studying products such as the cannabinoids identified in the study (which are already legal and available to consumers in 36 states for medical use and 18 for adult use) nearly impossible.
I know this from painful direct experience. I run a cannabis company in Colorado called Ripple, and the federal government has made it extraordinarily difficult and expensive for us to test our own products, even though part of the FDA’s mandate is protecting consumers. More testing and research benefits everyone.
The stated rationale for how…
Original Author Link klik hier om het volledige verhaal te lezen ..
By Justin Singer / Special To The Washington Post
A new study on cannabis compounds and the coronavirus got a lot of attention last week because it suggests that consuming certain cannabinoid acids may help treat or prevent covid-19. Predictably, the Internet was aflutter with the idea that the solution to the pandemic might be weed; which is very convenient if you already like weed.
“All this time we’ve been listening to the CDC, we should have been eating CBD,” Jimmy Kimmel joked on his show last Wednesday night. The study is promising and the excitement understandable, but the reality is that we won’t know whether cannabinoids are a safe and effective treatment for covid-19 until they’re tested in human trials.
This seems straightforward enough, but human trials take years in normal times for normal compounds. Meanwhile, we’re in covid times, and we’re talking about marijuana. And the Food and Drug Administration has made studying products such as the cannabinoids identified in the study (which are already legal and available to consumers in 36 states for medical use and 18 for adult use) nearly impossible.
I know this from painful direct experience. I run a cannabis company in Colorado called Ripple, and the federal government has made it extraordinarily difficult and expensive for us to test our own products, even though part of the FDA’s mandate is protecting consumers. More testing and research benefits everyone.
The stated rationale for how…
